Ken Pastor
Fondateur chez CTI Life Sciences Fund
Profil
Kenneth Pastor is the founder of CTI Life Sciences Fund.
He currently holds the position of Director at GLyPharma Therapeutic, Inc. and General Partner at CTI Capital, Inc. In the past, he worked as a Senior Business Developer at CTI Fonds Mutuels and CTI Capital Securities, Inc. Mr. Pastor completed his undergraduate degree at the University of Montréal.
Postes actifs de Ken Pastor
| Sociétés | Poste | Début |
|---|---|---|
GLyPharma Therapeutic, Inc.
 GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Directeur/Membre du Conseil | - |
CTI Capital, Inc.
 CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Private Equity Investor | - |
CTI Life Sciences Fund
 CTI Life Sciences Fund Miscellaneous Commercial ServicesCommercial Services CTI Life Sciences Fund provides life science related services. The private company is based in Montréal, Canada. The Canadian company was founded in 2006 by Kenneth Pastor. | Fondateur | - |
Anciens postes connus de Ken Pastor
| Sociétés | Poste | Fin |
|---|---|---|
CTI Capital Securities, Inc.
 CTI Capital Securities, Inc. Investment Banks/BrokersFinance CTI Capital Securities, Inc. (CTI) is the brokerage subsidiary of CTI Capital Groupe, Inc. The firm is headquartered in Montréal and was founded in 1987. CTI provides brokerage services in the fixed-income, money market and stock markets. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. Their equity research focuses on continuous global monitoring of the Canadian stock market. | Analyst-Fixed Income | - |
CTI Fonds Mutuels
 CTI Fonds Mutuels Investment ManagersFinance Founded in 1987, CTI Fond Mutuels is a mutual fund manager headquartered in Montreal, Quebec. The firm is a subsidiary of CTI Capital, Inc. They manage some of the CTI mutual funds. | Analyst-Fixed Income | 07/12/2010 |
Formation de Ken Pastor
| University of Montréal | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
CTI Fonds Mutuels
CTI Fonds Mutuels Investment ManagersFinance Founded in 1987, CTI Fond Mutuels is a mutual fund manager headquartered in Montreal, Quebec. The firm is a subsidiary of CTI Capital, Inc. They manage some of the CTI mutual funds. | Finance |
CTI Capital Securities, Inc.
CTI Capital Securities, Inc. Investment Banks/BrokersFinance CTI Capital Securities, Inc. (CTI) is the brokerage subsidiary of CTI Capital Groupe, Inc. The firm is headquartered in Montréal and was founded in 1987. CTI provides brokerage services in the fixed-income, money market and stock markets. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. Their equity research focuses on continuous global monitoring of the Canadian stock market. | Finance |
GLyPharma Therapeutic, Inc.
GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Health Technology |
CTI Capital, Inc.
CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Finance |
CTI Life Sciences Fund
CTI Life Sciences Fund Miscellaneous Commercial ServicesCommercial Services CTI Life Sciences Fund provides life science related services. The private company is based in Montréal, Canada. The Canadian company was founded in 2006 by Kenneth Pastor. | Commercial Services |
